Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

963986

registered interest
date	03/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	General Practitioners
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he has taken to make it easier for people to receive a GP appointment.
tabling member constituency	Crewe and Nantwich
tabling member printed	Laura Smith
uin	169775
answer	answer is ministerial correction date of answer 11/09/2018 answer text <p>The Government has committed to ensuring that by 2019 everyone in the country has easier and more convenient access to general practice services. This includes ensuring that access is available at peak times of demand, including bank holidays and across the Easter, Christmas and New Year periods.</p><p>The latest National Health Service planning guidance, published by NHS England in February 2018, brought forward the delivery timescale to 1 October 2018, to ensure additional capacity is in place ahead of winter 2018.</p><p>As part of the General Practice Forward View, published by NHS England in 2016, a number of initiatives were put in place to support practices and other providers to improve access to general practice services, building on successful approaches piloted through the GP Access Fund schemes. This includes delivering services at scale with better use of digital technology, using a wider workforce and enabling self-care and direct access to other services.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/09/2018 14:39:09 answering member 4067 label Biography information for Steve Brine
tabling member	4648 label Biography information for Laura Smith

963987

registered interest
date	03/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	General Practitioners
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he has taken to increase the number of GP's in more populated areas.
tabling member constituency	Crewe and Nantwich
tabling member printed	Laura Smith
uin	169776
answer	answer is ministerial correction date of answer 11/09/2018 answer text <p>NHS England and Health Education England (HEE) are working together with the profession to increase the general practitioner (GP) workforce. This includes measures to boost recruitment, address the reasons why GPs are leaving the profession, and encourage GPs to return to practice.</p><p>The number of doctors entering speciality training has been increasing year on year. In 2017/18, there were 3,157 new starters recruited to speciality GP training posts, the highest number recruited ever. A £20,000 salary supplement is also available to selected trainees committing to completing their training in areas of the country which have historically struggled to recruit trainees.</p><p>In August 2017 NHS England announced plans to accelerate its international recruitment programme and recruit 2,000 doctors into English general practice over the following three years. To boost retention there is a broad offer available to support GPs to remain in the NHS including the GP Health Service, the GP Retention Scheme, and the recently launched £10 million GP Retention Fund which includes funds targeted at specific areas.</p><p><strong> </strong></p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/09/2018 13:53:43 answering member 4067 label Biography information for Steve Brine
tabling member	4648 label Biography information for Laura Smith

963992

registered interest
date	03/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alcoholic Drinks: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to page 28 of the Government's 2017 Drug Strategy, published in July 2017, what assessment his Department has made of the (a) potential benefits and disbenefits of the proposals to use locally retained business rates for the funding of alcohol treatment services and (b) effect of those proposals on the provision of such services in deprived areas.
tabling member constituency	Bermondsey and Old Southwark
tabling member printed	Neil Coyle
uin	169387
answer	answer is ministerial correction date of answer 11/09/2018 answer text <p>It is for individual local authorities to decide what resources to commit to different public health services, including alcohol treatment services, to meet the needs of their local populations.</p><p> </p><p>Under the current system of 50% retained business rates, local authorities that receive more in business rates income than their baseline funding level contribute through a tariff, which is used to top up local authorities that receive less business rates income than their baseline funding level.</p><p> </p><p>The Government has been clear that under any future system there will continue to be redistribution of business rates between local authorities to take account of their relative needs.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/09/2018 16:11:00 answering member 4067 label Biography information for Steve Brine
tabling member	4368 label Biography information for Neil Coyle

963998

registered interest
date	03/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tuberculosis: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to provide financial support for research to small and medium-sized enterprises developing new tools for the (a) prevention, (b) diagnosis and (c) treatment of drug-resistant TB.
tabling member constituency	North East Fife
tabling member printed	Stephen Gethins
uin	169479
answer	answer is ministerial correction date of answer 11/09/2018 answer text <p>The Department funds research mainly through the National Institute for Health Research (NIHR). As the most integrated clinical research system in the world, we drive research from bench to bedside for the benefit of patients and the economy. The NIHR funds high quality research to improve health, trains and supports health researchers, provides world-class research facilities, works with the life sciences industry and charities to benefit all, and involves patients and the public at every step.</p><p> </p><p>The NIHR’s research programmes provide a flexible source of funding for researchers, including small and medium enterprises (SMEs), with the aim of improving public and patient health and care. Our Invention for Innovation (i4i) and Efficacy and Mechanism Evaluation programmes accept applications from SMEs as lead applicants collaborating with a National Health Service and/or academic partner. Other NIHR programmes accept applications from SMEs as co-applicants.</p><p> </p><p>Through the NIHR, the Government is also investing in research infrastructure in the NHS to ensure that we have the right facilities and people for a thriving research environment. The NIHR enables SMEs to access experts and develop collaborations within our world-leading infrastructure, supporting them to translate fundamental biomedical research into the clinical setting, run studies in the NHS and develop new treatments, diagnostics and medical devices.</p><p> </p><p>The NIHR welcomes funding applications for research into any aspect of human health, including drug resistant tuberculosis (TB); it is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p><p>Research on TB and drug resistant TB is supported by the Department nationally through the NIHR and internationally through support for research programmes delivered through other Government departments.</p><p> </p><p>Currently, a major part of the NIHR’s contribution to TB research is the Health Protection Research Unit (HPRU) on Respiratory Infections at Imperial College London. This started in 1 April 2014 and has received funding of £4.21 million. The HPRU is a collaboration between Public Health England, Imperial College and Oxford University and undertakes research on diagnostics, surveillance, treatment and management of TB.</p><p> </p><p>Globally, the Department for Health and Social Care supports research on TB by SMEs through the Department for International Development (DFID). DFID is the UK Government’s lead to the Global Alliance for TB Drug Development (TB Alliance) a not-for-profit product-development-partnership dedicated to the discovery, development and delivery of better, faster-acting and affordable TB drugs; and the Foundation for Innovative New Diagnostics (FIND), which includes TB as one of its priority diseases. In 2017, the Department also provided financial support for research with a £4.5 million one off contribution through its Overseas Development Assistance (ODA) budget to the TB Alliance. The TB Alliance and FIND work with many different partners in the public, private (i.e. industry including SMEs), academic, and philanthropic sectors in a wide range of countries across the globe to develop new treatments and diagnostics for TB, including drug sensitive and drug resistant TB.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 11/09/2018 13:52:31 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4434 label Biography information for Stephen Gethins

964003

registered interest
date	03/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if the Government will adopt Macmillan Cancer Support's five recommendations as recently published on its website page entitled Support our vision for the future of the NHS.
tabling member constituency	Brighton, Kemptown
tabling member printed	Lloyd Russell-Moyle
uin	169710
answer	answer is ministerial correction date of answer 06/09/2018 answer text <p>Following the Government announcement of a new financial settlement for the National Health Service, NHS England is consulting cancer stakeholders on their experiences and priorities for cancer care in England, including evidence of what has worked. This will feed into the wider NHS ten-year plan to improve services and care, build on the progress already made in implementing the recommendations of the independent Cancer Taskforce’s 2015 report (Achieving World-Class Cancer Outcomes: A strategy for England 2015-2020) and address the five points in Macmillan Cancer Support’s vision for the future of the NHS.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/09/2018 10:36:00 answering member 4067 label Biography information for Steve Brine
tabling member	4615 label Biography information for Lloyd Russell-Moyle

964009

registered interest
date	03/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the effect of clinical commissioning groups' commissioning of FreeStyle Libre glucose monitoring technology on patients' access to that technology throughout England.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	169910
answer	answer is ministerial correction date of answer 06/09/2018 answer text <p>New figures from NHS England indicate that the majority, around 140 out of 195 clinical commissioning groups (CCGs) have now approved FreeStyle Libre or uptake. Earlier this year NHS England wrote to CCGs reminding them of their responsibilities and of the guidance that exists when it comes to flash glucose monitoring, and other treatments for people with type 1 diabetes.</p><p> </p><p>NHS England continues to work with CCGs to encourage them to adopt best practice.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/09/2018 10:33:05 answering member 4067 label Biography information for Steve Brine
tabling member	1538 label Biography information for Rosie Cooper

964016

registered interest
date	03/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Anticoagulants
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when his Department plans to complete the peer review of the systematic overview of reviews on the effective, safe and appropriate use of anticoagulation medicines undertaken by the Evidence for Policy and Practice Information and Co-ordinating Centre; and when that final report will be published.
tabling member constituency	Huddersfield
tabling member printed	Mr Barry Sheerman
uin	169005
answer	answer is ministerial correction date of answer 11/09/2018 answer text <p>‘The effective, safe and appropriate use of anticoagulation medicines: A systematic overview of reviews' has been peer reviewed and was published in July 2018. It is available at the following link:</p><p> </p><p><a href="http://eppi.ioe.ac.uk/cms/Default.aspx?tabid=3733" target="_blank">http://eppi.ioe.ac.uk/cms/Default.aspx?tabid=3733</a></p><p> </p><p>The Department, NHS England and members of the Anticoagulants Advisory Committee, a group of external academic and clinician advisors with expertise in anticoagulation therapy, were consulted on the protocol. The Reviews Facility, which is led by the EPPI-Centre and includes the Centre for Reviews and Dissemination at the University of York and the London School of Hygiene and Tropical Medicine, carried out the review independently. Amendments were made to the report following peer review.</p><p> </p><p>The Department currently has no plans to hold a consultation on the findings.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 169006 169007 question first answered 11/09/2018 13:54:14 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	411 label Biography information for Mr Barry Sheerman

964017

registered interest
date	03/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Anticoagulants
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, which stakeholders were involved in (a) developing the protocol for and (b) conducting the systematic overview of reviews on the effective, safe and appropriate use of anticoagulation medicines undertaken by the Evidence for Policy and Practice Information and Co-ordinating Centre.
tabling member constituency	Huddersfield
tabling member printed	Mr Barry Sheerman
uin	169006
answer	answer is ministerial correction date of answer 11/09/2018 answer text <p>‘The effective, safe and appropriate use of anticoagulation medicines: A systematic overview of reviews' has been peer reviewed and was published in July 2018. It is available at the following link:</p><p> </p><p><a href="http://eppi.ioe.ac.uk/cms/Default.aspx?tabid=3733" target="_blank">http://eppi.ioe.ac.uk/cms/Default.aspx?tabid=3733</a></p><p> </p><p>The Department, NHS England and members of the Anticoagulants Advisory Committee, a group of external academic and clinician advisors with expertise in anticoagulation therapy, were consulted on the protocol. The Reviews Facility, which is led by the EPPI-Centre and includes the Centre for Reviews and Dissemination at the University of York and the London School of Hygiene and Tropical Medicine, carried out the review independently. Amendments were made to the report following peer review.</p><p> </p><p>The Department currently has no plans to hold a consultation on the findings.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 169005 169007 question first answered 11/09/2018 13:54:14 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	411 label Biography information for Mr Barry Sheerman

964018

registered interest
date	03/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Anticoagulants
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department plans to hold a consultation on the findings of the systematic overview of reviews on the effective, safe and appropriate use of anticoagulation medicines undertaken by the Evidence for Policy and Practice Information and Co-ordinating Centre.
tabling member constituency	Huddersfield
tabling member printed	Mr Barry Sheerman
uin	169007
answer	answer is ministerial correction date of answer 11/09/2018 answer text <p>‘The effective, safe and appropriate use of anticoagulation medicines: A systematic overview of reviews' has been peer reviewed and was published in July 2018. It is available at the following link:</p><p> </p><p><a href="http://eppi.ioe.ac.uk/cms/Default.aspx?tabid=3733" target="_blank">http://eppi.ioe.ac.uk/cms/Default.aspx?tabid=3733</a></p><p> </p><p>The Department, NHS England and members of the Anticoagulants Advisory Committee, a group of external academic and clinician advisors with expertise in anticoagulation therapy, were consulted on the protocol. The Reviews Facility, which is led by the EPPI-Centre and includes the Centre for Reviews and Dissemination at the University of York and the London School of Hygiene and Tropical Medicine, carried out the review independently. Amendments were made to the report following peer review.</p><p> </p><p>The Department currently has no plans to hold a consultation on the findings.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 169005 169006 question first answered 11/09/2018 13:54:14 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	411 label Biography information for Mr Barry Sheerman

964034

registered interest
date	03/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Sheffield Hallam
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the proposed average payments to community pharmacies were in Sheffield Hallam constituency under the Pharmacy Access Scheme in (a) 2016-17 and (b) 2017-18.
tabling member constituency	Sheffield, Hallam
tabling member printed	Jared O'Mara
uin	169826
answer	answer is ministerial correction date of answer 11/09/2018 answer text <p>The average payments for community pharmacies located in the Sheffield Hallam constituency made through the Pharmacy Access Scheme were:</p><p>£8,007 per year in 2016/17; and</p><p>£15,173 per year in 2017/18.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/09/2018 14:10:28 answering member 4067 label Biography information for Steve Brine
tabling member	4661 label Biography information for Jared O'Mara